DJIA 18,030.21 6.04 0.03%
NASDAQ 4,773.47 8.05 0.17%
S&P 500 2,081.88 -0.29 -0.01%
market minute promo

MannKind Corp (NASDAQ: MNKD)



company name or ticker

News From Sanofi About MannKind's Afrezza And Its Future

3 Scary Stocks to Avoid

Frightening uncertainty may mean that Dendreon, MannKind, and GW Pharma are three of the stock market's scariest stocks.

MannKind: What The Market's Implying, And Why It's Wrong.

Is Sanofi's Ouster of Viehbacher a Mistake?

Sanofi has jettisoned its long time CEO, but that might not be the best decision given challenges that lay ahead.

MannKind: What To Expect From Earnings

How MannKind Long Investors Can Profit From Short Raids

Could MannKind Corporation Be Running Out of Money?

A biotech stock running out of money is perhaps the biggest concern healthcare investors have. Find out if MannKind has the cash on hand to successfully execute on its business strategy.

Insuline: Significant Upside, Alternative Diabetes Play With A Population Based Cost-Reduction Platf

Insuline: Significant Upside, Alternative Diabetes Play With A Population Based Cost-Reduction Platform In Diabetes

Forget MannKind Corporation: 3 Better Stocks

Three Motley Fool analysts weigh in on which companies they think are better bets than MannKind.

MannKind: Massive Short Interest Could Lead To Big Gains

See More Articles...